Concurrently, the increase in phosphorylated PTEN suggests enhanced PTEN activity, which negatively regulates the PI3K/Akt/mTOR pathway, thereby inhibiting mTOR signaling and potentially reducing tumor growth and progression [30]. The gene discussed is PTEN; the disease is neoplasm.